Is glycated hemoglobin level a sensitive indicator of new-onset diabetes after renal transplantation?
Mariana Markell
Correspondence Division of Renal Diseases, SUNY Downstate Medical Center, 450 Clarkson Ave, Box 52, Brooklyn, NY 11203, USA
Email mmarkell@downstate.edu
This article has no abstract so we have provided the first paragraph of the full text.
Diabetes that occurs de novo after organ transplantation, variously called 'post-transplantation diabetes' and, more recently, new-onset diabetes after transplantation (NODAT), has been recognized since the earliest era of transplantation. Its reported prevalence varies widely, because of the use of inconsistent and often seemingly random definitions of diabetes.1 An expert consensus panel convened in 20032 and 20043 agreed that the definition of NODAT should be in accordance with the American Diabetes Association (ADA)'s definition of diabetes mellitus, which specifies an FPG level 
126 mg/dl (7.0 mmol/l), a random blood sugar level 200 mg/dl (11.1 mmol/l) accompanied by symptoms, or an oral glucose tolerance test (OGTT) value 200 mg/dl.
Full text of this article is available with one of the following:
- Membership of the International Society of Nephrology. If already a member, please login. If not please join the Society now
- Personal subscription Purchase your own personal subscription to this journal. Already a subscriber? Please login for immediate access.
- 7 day single article pass for US$18 In order to purchase this article you must be a registered user. Please register or login above.
- Site licence Learn more about institutional site licences
Current Subscribers
Please log in to access the full text article using the login box at the top of the page.
